Grantham, Mayo, Van Otterloo & Co (GMO)’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.3M Buy
214,118
+87,842
+70% +$12.8M 0.07% 128
2026
Q2
$18.3M Buy
126,276
+87,406
+225% +$10.9M 0.04% 190
2026
Q1
$4.13M Sell
38,870
-1,428
-4% -$162K 0.01% 349
2025
Q4
$4.28M Buy
+40,298
New +$4.07M 0.01% 330
2021
Q1
– Sell
-23,800
Closed -$1.31M – 833
2020
Q4
$1.31M Sell
23,800
-52,100
-69% -$2.66M 0.01% 521
2020
Q3
$3.35M Sell
75,900
-22,800
-23% -$1M 0.02% 308
2020
Q2
$4.16M Buy
98,700
+9,300
+10% +$358K 0.03% 270
2020
Q1
$3.55M Buy
+89,400
New +$3.78M 0.03% 292

Other funds holding ACA

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACA Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Arcosa (ACA) stake by 70% in Q3 2026, buying an estimated $12.8M and bringing the position to 214,118 shares worth $31.3M. The position accounts for 0.07% of the portfolio, ranked #128.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACA in Q1 2020 and has held it in 8 quarters since. 422 funds tracked by Wall St. Rank hold ACA as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 214,118 shares of Arcosa worth $31.3M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 87,842 Arcosa shares in Q3 2026, an estimated $12.8M.
  • Arcosa made up 0.07% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #128 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Arcosa in Q1 2020 and has held it in 8 quarters since.
  • 422 funds tracked by Wall St. Rank held Arcosa as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.